Treatment-refractory Metastatic Breast Cancer: New Options & Emerging StrategiesTreatment-refractory Metastatic Breast Cancer: New Options & Emerging Strategies Faculty: Deborah L. Toppmeyer, MD | Angela DeMichele, MD, MSCE | Clifford A. Hudis, MD CME credit hours: 1.0 Join us as leading experts in the field of metastatic breast cancer discuss the challenges and therapeutic options for the management of treatment-refractory metastatic breast cancer. Dr Hudis begins with a review of evidence-based options for the management of HER 2+ breast cancer patients followed by Dr DeMichele who provides insight on standard chemotherapy options and future options for patients resistant to treatment. At the conclusion of the 1-hour webcast portion worth 1 CME credit, a lively interactive case based discussion is available that features Dr Toppmeyer and the faculty panel discussing their expert opinion on best practices for patients with advanced metastatic breast cancer.
All information content within shall be considered confidential property of ArcMesa Educators, LLC
and should not be disclosed or redistributed to third parties without express permission.
